£192.99

Burkitt Lymphoma: Updates in Etiology, Symptoms, Molecular Genetics and Treatment Options

Price data last checked 109 day(s) ago - refreshing...

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

About as cheap as it gets. The only time it was cheaper was 2 years ago.

£193 today · all-time low £186 (Jun 2024) · usually the usual

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 622 days • 622 data points (No recent data available)

Historical
Generating forecast...
£545.99 £149.99 £236.39 £322.79 £409.19 £495.59 £581.99 17 June 2024 19 November 2024 23 April 2025 25 September 2025 28 February 2026

Price Distribution

Price distribution over 622 days • 5 price levels

Days at Price
Current Price
7 days 19 days 391 days · current 30 days 175 days 0 98 196 293 391 £186 £190 £193 £539 £546 Days at Price

Price Analysis

Most common price: £193 (391 days, 62.9%)

Price range: £186 - £546

Price levels: 5 different prices over 622 days

Description

Burkitt lymphoma (BL) is a lymphoid neoplasm originating from a mature, follicular center B-cell that is phenotypically positive for CD10, BCL-6, LOM2, and HGAL, with a hallmark genetic translocation involving the MYC gene (at 8q24) and its partner either immunoglobulin heavy chain (14q) or light chain (kappa at 2q and lambda at 22q) and a very aggressive clinical nature. BL can be divided into three clinical subcategories: Endemic, sporadic and HIV/AIDS/immunodeficiency with prevalence in children, adolescents and young adults. Clinical manifestations could slightly be variable upon its clinical subcategories; however, they share certain similar features, e.g., fast growing mass, frequent extranodal presentation, are associated with EBV infection, and sensitive to tumor reduction therapy with a high risk of tumor lysis syndrome and uric acid nephropathy. It is important to differentiate BL from other aggressive types of B-cell lymphomas as with intensive, short-term chemotherapy, (eg: hyper-CVAD (hyperfractionated cyclophosphamide, vincristine, doxorubicin, dexamethasone, methotrexate, and cytarabine). Additionally, CNS prophylaxis BL showed a much better clinical response. Nearly all types of BL lack or dimly express BCL-2, differentiating it from other mimickers. A diagnostic challenging variant of BL an MYC-negative harboring 11q abnormalities, namely Burkitt-like lymphoma with an 11q aberration has been recently proposed. Novel next generation sequencing and gene expression profiling has brought about new insights into BL. TCF3(E2A), a transcription factor involving the regulation of lymphoid cell survival and proliferation, its negative regulator known as ID3, and the downstream gene CCND3 were also frequently mutated in cases of BL. The characterization of molecular biology and the genetic profile of BL leads to the future of personalized medicine and targeted therapy. This book focuses on the epidemiology, etiology, clinical presentations/staging, differential diagnoses, MYC-driven pathogenesis and therapeutic options concerning BL. These updates in BL and associated EBV- or MYC-positive diseases will benefit trainees, physicians and basic scientists who engage in the diagnosis, treatment, and novel drug development for this disease.

Product Specifications

Format
hardcover
Domain
Amazon UK
Release Date
18 October 2018
Listed Since
30 June 2018

Barcode

No barcode data available

Similar Products You Might Like

Ablashi: ∗epstein–bar Virus∗ & Human Disease 1988: 20 (Experimental Biology and Medicine, 20)
97% match

Ablashi: ∗epstein–bar Virus∗ & Human Disease 1988: 20 (Experimental Biology and Medicine, 20)

Humana

£87.00 05 Mar 2026
Epstein-Barr Virus: Latency and Transformation
97% match

Epstein-Barr Virus: Latency and Transformation

Caister Academic Press Limited

£198.66 11 Apr 2026
Epstein-Barr Virus
97% match

Epstein-Barr Virus

Caister Academic Press Limited

£242.15 22 Jan 2026
Epstein-Barr Virus and Human Cancer: v.258 (Current Topics in Microbiology and Immunology)
96% match

Epstein-Barr Virus and Human Cancer: v.258 (Current Topics in Microbiology and Immunology)

Springer

£78.46 09 Mar 2026
Levine: ∗epstein–barr Virus∗ & Human Disease (prev. Ebv & Associated Disease): 15 (Experimental Biology and Medicine, 15)
96% match

Levine: ∗epstein–barr Virus∗ & Human Disease (prev. Ebv & Associated Disease): 15 (Experimental Biology and Medicine, 15)

Humana

£89.61 09 Mar 2026
Epstein-Barr Virus and Human Disease · 1990: 24 (Experimental Biology and Medicine, 24)
96% match

Epstein-Barr Virus and Human Disease · 1990: 24 (Experimental Biology and Medicine, 24)

Humana

£108.78 18 Apr 2026
Benign and Reactive Conditions of Lymph Node and Spleen Atlas
96% match

Benign and Reactive Conditions of Lymph Node and Spleen Atlas

£105.55 15 Apr 2026
Follicular Lymphoma and Mantle Cell Lymphoma: Pathobiology, Diagnosis and Treatment (Molecular and Translational Medicine)
96% match

Follicular Lymphoma and Mantle Cell Lymphoma: Pathobiology, Diagnosis and Treatment (Molecular and Translational Medicine)

Humana

£77.74 10 Mar 2026
Diagnosis and Therapy of Malignant Lymphoma: 46 (Recent Results in Cancer Research, 46)
95% match

Diagnosis and Therapy of Malignant Lymphoma: 46 (Recent Results in Cancer Research, 46)

Springer

£77.39 11 Mar 2026
Post-Transplant Lymphoproliferative Disorders
95% match

Post-Transplant Lymphoproliferative Disorders

Springer

£128.11 12 Apr 2026
EPSTEIN BARR VIRUS EBV TRANSMISSION: Transmission, Diagnosis & Role in the Development of Cancers (Virology Research Progress)
95% match

EPSTEIN BARR VIRUS EBV TRANSMISSION: Transmission, Diagnosis & Role in the Development of Cancers (Virology Research Progress)

£106.00 27 Jan 2026
Ioachim's Lymph Node Pathology
95% match

Ioachim's Lymph Node Pathology

Lippincott Williams & Wilkins

£147.80 17 Mar 2026
Diagnostic Pathology: Lymph Nodes and Extranodal Lymphomas
95% match

Diagnostic Pathology: Lymph Nodes and Extranodal Lymphomas

Elsevier

£181.95 29 Jan 2026
Molecular Biology of B-Cell and T-Cell Development (Contemporary Immunology)
95% match

Molecular Biology of B-Cell and T-Cell Development (Contemporary Immunology)

Humana

£149.15 08 Mar 2026
Lymphoma: Methods and Protocols: 1956 (Methods in Molecular Biology, 1956)
95% match

Lymphoma: Methods and Protocols: 1956 (Methods in Molecular Biology, 1956)

Humana

£117.00 28 Feb 2026
The Cutaneous Lymphoid Proliferations: A Comprehensive Textbook of Lymphocytic Infiltrates of the Skin
95% match

The Cutaneous Lymphoid Proliferations: A Comprehensive Textbook of Lymphocytic Infiltrates of the Skin

Wiley-Blackwell

£199.82 21 Jan 2026
Blut und Blutkrankheiten: Fünfte Völlig Neu Bearbeitete und Erweiterte Auflage: 2 / 7 (Handbuch der inneren Medizin, 2 / 7)
95% match

Blut und Blutkrankheiten: Fünfte Völlig Neu Bearbeitete und Erweiterte Auflage: 2 / 7 (Handbuch der inneren Medizin, 2 / 7)

Springer

£57.70 19 Apr 2026
Epstein-Barr Virus Protocols: 174 (Methods in Molecular Biology, 174)
95% match

Epstein-Barr Virus Protocols: 174 (Methods in Molecular Biology, 174)

Humana

£108.78 20 Apr 2026
Humana Lymphoma: Methods and Protocols - Methods in Molecular Biology
95% match

Humana Lymphoma: Methods and Protocols - Methods in Molecular Biology

Humana

£101.00 18 Apr 2026
Epstein-Barr Virus & Associated Diseases (Colloque INSERM: 225)
95% match

Epstein-Barr Virus & Associated Diseases (Colloque INSERM: 225)

£78.86 14 Feb 2026
Niels Kaj Jerne: A Portrait of the Immune System - Book 2
95% match

Niels Kaj Jerne: A Portrait of the Immune System - Book 2

World Scientific Publishing Company

£121.00 18 Apr 2026
Histopathology of Non-Hodgkin’s Lymphomas: (Based on the Updated Kiel Classification)
95% match

Histopathology of Non-Hodgkin’s Lymphomas: (Based on the Updated Kiel Classification)

Springer

£77.82 11 Mar 2026
Skin Lymphoma: The Illustrated Guide
95% match

Skin Lymphoma: The Illustrated Guide

Wiley-Blackwell

£100.68 23 Jan 2026
Hematopathology
95% match

Hematopathology

Elsevier

£187.31 18 Mar 2026